drug
(insulin lispro + insulin lispro protamine)
Marketedupdated 3mo agoby Lilly USA LLC
Approvedcommunity read0 votes
all catalysts(0)
nothing on the calendar yet
Trials studying (insulin lispro + insulin lispro protamine)
- N/AUltrarapid Insulin Administered by a Bihormonal Closed Loop System in Patients With Type 1 Diabetes
- phase1A Study of LY3938577 in Healthy Participants and Participants With Type 1 Diabetes Mellitus (T1DM)
- phase3Efficacy and Safety of THDB0206 Compared to Insulin Lispro Injection in Participants With Type 2 Diabetes
- phase3Efficacy and Safety of THDB0206 Compared to Insulin Lispro Injection in Participants With Type 1 Diabetes
- N/AA Study of LY8888AX in Participants Using a Connected Insulin Management Platform
- phase4A Study of LY900014 in Adult Participants With Type 2 Diabetes Mellitus in India
- phase1A Bioequivalence Study Comparing Two Different Strengths Formulations of Insulin Lispro in Patients With Type 1 Diabetes
- phase3A Study of Insulin Efsitora Alfa (LY3209590) as a Weekly Basal Insulin Compared to Insulin Glargine in Adult Participants With Type 2 Diabetes on Multiple Daily Injections
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 18m ago
Found something off?
comments(0)
5-min edit window · permanent after that